Multiple Sclerosis Treatment Report

This page tracks new and upcoming treatment options for multiple sclerosis (MS). What’s in development? What’s promising? What’s available soon? Current topics include ABX-002, BIIB061, ALKS 8700, CNM-Au8, Dapansutrile, IMU-838, EHP-101, ofatumumab, stem cells, NLRP, FMT, icariin, evobrutinib, and more. Jump to section: News, Research, Clinical Trials

Last updated: 4 years ago

News

Regulatory T cells could lead to new immunotherapies aimed at treating multiple sclerosis Sep 21, 2020
Novartis data at ACTRIMS-ECTRIMS highlight the strength of leading multiple sclerosis (MS) portfolio with life-changing therapies for people across the MS spectrum Sep 8, 2020
#MSVirtual2020 – Meeting Focus Is on Advances in MS Research, Diagnostics, and Technology Sep 4, 2020
SomaCeuticals Acquires License for Treatment of Multiple Sclerosis Aug 24, 2020
Key gene identified for improving multiple sclerosis treatment Aug 14, 2020
“Reelin” In A New Treatment For Multiple Sclerosis – Depleting key protein could protect against conditions marked by chronic inflammation Aug 12, 2020
Drug prevents multiple sclerosis relapses in phase 3 trial Aug 5, 2020
Immunic’s multiple sclerosis med IMU-838 trounces placebo in phase 2 Aug 3, 2020
Hookworm trial offers new hope to MS patients Jun 18, 2020
Helius Medical Technologies, Inc. Announces FDA Has Granted the PoNS Device Breakthrough Device Designation for the Treatment of Gait Deficits Due to Symptoms of Multiple Sclerosis May 12, 2020
2020 Dystel Prize for MS Research Goes to Dr. Ian Duncan for Advances in Understanding Myelin Repair May 11, 2020
VBL First-in-class MOSPD2 Antibodies Show Potential for Treatment of Multiple Sclerosis May 4, 2020
Compound in fruit peels halts damage and spurs neuronal repair in multiple sclerosis – Ursolic acid, abundant in fruit peels and some herbs, both prevents and repairs neurons in animal models of MS Apr 6, 2020
#ACTRIMS2020 – CNM-Au8 a Potential ‘Breakthrough’ in MS Therapy, Clene CMO Says Mar 16, 2020
MedDay Reports Top-Line Data from Phase 3 Trial SPI2 for Treatment of Progressive Forms of Multiple Sclerosis: MD1003 fails to meet its primary and secondary endpoints Mar 10, 2020
New multiple sclerosis treatment trial compares stem cell transplantation to best available drugs Jan 7, 2020
Flashing lights may provide vital first test of multiple sclerosis drug success Dec 16, 2019
Study shows the progression of multiple sclerosis can be slowed – without some of the health risks associated with current treatments Nov 25, 2019
New Potential Multiple Sclerosis Treatment Being Tested In Canada Nov 25, 2019
Liberation therapy: What we know about the controversial MS treatment 10 years later Nov 22, 2019
Mallinckrodt Announces Data Publication on the Treatment Effectiveness of Acthar® Gel (Repository Corticotropin Injection) for Resolution of Multiple Sclerosis Relapse Nov 7, 2019
New research to stop Multiple Sclerosis Oct 28, 2019
Clene Nanomedicine Awarded Research Grant from the National Multiple Sclerosis Society to Support Clinical Development of its Lead Nanocatalytic Therapeutic, CNM-Au8 Oct 14, 2019
University of Virginia team discovers surprise contributor to multiple sclerosis Oct 7, 2019
Targeting certain rogue T cells prevents and reverses multiple sclerosis in mice Oct 4, 2019
Diabetes drug offers hope of new treatment for multiple sclerosis: Trial using rats showed the drug metformin repaired nerve damage caused by the disease Oct 2, 2019
Trigger for MS and Other Immune Diseases May Be T-cells in Early Activation State, Study Reports Sep 30, 2019
Genomic map implicates broad immune cell involvement in multiple sclerosis Sep 26, 2019
UB researchers discover clues to boost MS diagnosis, treatment Sep 25, 2019
Myelin Repair, Clinical Trials, Gut Bacteria, and Exercise Headline at ECTRIMS2019, the World’s Largest MS Research Meeting Sep 23, 2019
Researchers develop a promising new ‘Trojan horse’ treatment for multiple sclerosis Sep 19, 2019
Author J.K. Rowling Donates $18.8 Million to Research Into the Treatment of Multiple Sclerosis Sep 15, 2019
First results of new stem cell therapy trial announced Sep 12, 2019
Mapi Pharma to Present Series of Recent Advancements for Treating Multiple Sclerosis (MS) at ECTRIMS 2019 Sep 4, 2019
The Road to Better Multiple Sclerosis Therapy Aug 28, 2019
After Her Years of Research, a Cambridge Scientist Could Be on the Verge of Curing Multiple Sclerosis Aug 25, 2019
Four women now in remission from multiple sclerosis thanks to experimental treatment Aug 15, 2019
Cyxone Announce Dosing of First Patient in First-In-Human Trial of T20K, in Development for the Treatment of Multiple Sclerosis (MS) Jul 12, 2019
Emerald Health Pharmaceuticals Demonstrates Repair of Nerve Damage Related to Multiple Sclerosis: Preclinical data show remyelination with the clinical-stage drug product candidate, EHP-101 Jul 2, 2019
Nanotechnology treatment shows promise against multiple sclerosis Jun 5, 2019
Celgene Submits Application to EMA for Ozanimod for the Treatment of Relapsing-Remitting Multiple Sclerosis Mar 11, 2019
How metabolites target brain-homing immune cells to treat multiple sclerosis Feb 28, 2019
New compound offers superior therapeutic approach to treat MS Feb 21, 2019

Research

Clinical Trials

Projects

Discussion

Back to top